DeLellis R A, Kwan P
Department of Pathology, Tufts University School of Medicine, Boston, MA 02111.
Am J Surg Pathol. 1988;12 Suppl 1:17-23.
The intermediate filaments represent an important group of differentiation markers that have proven to be useful for the diagnosis and classification of human neoplasms. The immunohistochemical demonstration of these proteins is subject to numerous technical variables that include specificities and patterns of reactivities of polyclonal antisera and monoclonal antibodies, cross-reactivities of "specific" monoclonal antibodies with other intermediate filaments and other classes of antigens, masking of certain epitopes due to physiologic or pathologic changes in cells, effects of tissue fixation and subsequent tissue processing, and the sensitivity of the particular immunohistochemical detection system employed. Moreover, a wide variety of microenvironmental signals may affect the patterns of expression of intermediate filament proteins in different pathological conditions. For accurate interpretation of intermediate filament immunoreactivity, the pathologist must be familiar with the various sources of error relating to false positive or negative results. This requires the availability of optimally fixed tissues, a well-characterized set of antibodies to intermediate filament antigens and access to the results of extensive performance testing.
中间丝代表了一组重要的分化标志物,已被证明对人类肿瘤的诊断和分类有用。这些蛋白质的免疫组织化学显示受到众多技术变量的影响,这些变量包括多克隆抗血清和单克隆抗体的特异性和反应模式、“特异性”单克隆抗体与其他中间丝及其他类抗原的交叉反应、由于细胞的生理或病理变化导致某些表位的掩盖、组织固定及后续组织处理的影响,以及所采用的特定免疫组织化学检测系统的敏感性。此外,各种各样的微环境信号可能在不同病理状况下影响中间丝蛋白的表达模式。为准确解释中间丝免疫反应性,病理学家必须熟悉与假阳性或假阴性结果相关的各种误差来源。这需要有最佳固定的组织、一套特性明确的针对中间丝抗原的抗体,以及获得广泛性能测试结果的途径。